Nicholas Drago is Assistant Director of Regulatory Policy & Intelligence at Bayer Pharmaceuticals. In this role, he leads several projects that seek to apply innovative technology and data science in Regulatory Affairs. He has over 6 years of experience in Regulatory Affairs. Nicholas holds a degree in biology from the University of Rochester.
|1:55 PM - 2:25 PM||
Applying AI to Augment Regulatory Affairs Knowledge
Technological capabilities in the area of AI are advancing rapidly. Meanwhile, data is being collected from numerous sources, from electronic health records to wearable devices. In addition, the drug development landscape is becoming more transparent as further data is made publicly available. AI can be used to analyze this data and facilitate access to information and insights needed to formulate drug development and regulatory strategies. This presentation will examine opportunities and challenges related to the use of data science and AI to better understand and innovate within the regulatory environment.